Participation in a women's breast cancer risk counseling trial: Who participates? Who declines?

Cancer

Volumn 77, Issue 11, 1996, Pages 2348-2355

  Rimer, Barbara K ^a   Schildkraut, Joellen M ^a   Lerman, Caryn ^b   Lin, Ting Hsiang ^b   Audrain, Janet ^b  

^a DUKE CANCER INSTITUTE   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

breast cancer; counseling; genetic risk; predictors

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CONTROL; CANCER RESEARCH; CANCER RISK; EMOTION; FEMALE; GENETIC RISK; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MENTAL STRESS; MULTIVARIATE ANALYSIS; PATIENT COUNSELING; PREDICTION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT;

ADULT; AGED; ALCOHOL DRINKING; ATTITUDE TO HEALTH; BREAST NEOPLASMS; BREAST SELF-EXAMINATION; CONTINENTAL POPULATION GROUPS; COUNSELING; EDUCATIONAL STATUS; EMOTIONS; FAMILY HEALTH; FEMALE; HEALTH EDUCATION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT PARTICIPATION; PATIENT SELECTION; REPRODUCTIVE HISTORY; RISK; RISK FACTORS; SMOKING; SOCIOECONOMIC FACTORS; TIME FACTORS;

EID: 0029956049     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960601)77:11<2348::AID-CNCR25>3.0.CO;2-W     Document Type: Article

References (33)

1. Office of Research on Women's Health, In Recruitment and Retention of Women in Clinical Studies. Bethesda (MD): National Institutes of Health, U.S. Department of Health and Human Services; 1995 NIH Publication No. 95-3756.
2. Hunninghake DB, Darby CA, Probstfield JL. Recruitment experience in clinical trials: literature summary and annotated bibliography. Control Clin Trials 1987;8(Suppl):6S.
3. Greenwald P, Sondik PJ, Young JL. Emerging roles for cancer registries in cancer control. Yale J Biol Med 1986;59:56.
4. Zelen M. Are primary cancer prevention trials feasible? J Natl Cancer Inst 1988;80:1442.
5. Stein REK, Bauman LJ, Ireys HT. Who enrolls in prevention trials? Discordance in perception of risk by professionsals and participants. Am J Community Psychol 1991;19(4):603.
6. Stevens M, Greenberg ER, Baron JA. Practical aspects of cancer prevention trials. In: Moon T, Micozzi M, (editors). Nutrition and cancer prevention. New York: Marcel Dekker, 198:513.
7. Levanthal H, Nerenz DR, Leventhal EA, Love RR, Bendena LM. The behavioral dynamics of clinical trials. Presented at "Workshop: Antiestrogen Prevention of Breast Cancer." Madison, Wisconsin, October 2-4, 1989.
8. Yeomans-Kinney A, Vernon SW, Frankowski RF, Weber DM, Bitsura JM, Vogel VG. Factors related to enrollment in the breast cancer prevention trial at a comprehensive cancer center during the first year of recruitment. Cancer 1995; 76(1):46.
9. Agras WS, Bradford RH. Recruitment: an introduction. Circulation 1982;66(Suppl IV):2.
10. Rosenthal R, Rosnow RL. The volunteer subject. New York: Wiley, 1975.
11. Rosnow RL, Rosenthal R. The volunteer subject revisited. Aust J Psychol 1976;28:97.
12. Paskett ED, Carter WB, Chu J, White E. Compliance behavior in women with abnormal pap smears. Developing and testing a decision model. Med Care 1990;28:643.
13. Lerman C, Rimer BK, Engstrom PF. Cancer risk notification: psychosocial and ethical implications. J Clin Oncol 1991; 9:1275.
14. Kash KM, Holland JC, Halper MS, Miller DG. Psychological distress and surveillance behaviors of women with a family history of breast cancer. J Natl Cancer Inst 1992;84:24.
15. Lerman C, Daly M, Sands C, Balshem A, Lustbader E, Heggan T, et al. Psychological distress interferes with mammography adherence among women at risk for breast cancer. J Natl Cancer Inst 1993;85:1074.
16. Lerman C, Trock B, Rimer BK, Boyce A, Jepson C, Engstrom PF. Psychological and behavioral implications of abnormal mammograms. Ann Intern Med 1991;114:657.
17. Nayfield SG, Karp JE, Ford LG, Dorr FA, Kramer BS. Potential role of tamoxifen in prevention of breast cancer. J Natl Cancer Inst 1991;83:1450.
18. Lerman C, Rimer BK, Daly M, Lustbader E, Sands C, Balshem A, et al. Recruiting high risk women into a breast cancer health promotion trial. Cancer Epidemiol Biomarkers Prev 1994;3:271.
19. Miki Y, Swensen J, Shalluck-Eidens D, Futreal PA, Harshman K, Tavtigians S, et al. A strong candiate for the breast and ovarian suscptibility gene BRCA1. Science 1994;266:5182:66.
20. Audrain J, Lerman C, Rimer BK, Cella D, Steffens R, Gomez-Caminero A. High risk breast cancer consortium. Awareness of heightened breast cancer risk among first-degree relatives of recently diagnosed breast cancer patients. Cancer Epidemiol Biomarkers Prev 1995;4:561.
21. Lerman C, Schwartz M. Adherence and psychological adjustment among women at high risk for breast cancer. Br Cancer Res Treat 1993;28:145.
22. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, et al. Projecting individualized probabilities of developing breast cancer for white females who are being screened annually. J Natl Cancer Inst 1989;81:1879.
23. Gail MH, Benichou I. Assessing the risk of breast cancer in individuals. In: DeVita VT Jr, Hellman S, Rosenberg SA, editors. Cancer Prevention. Philadelphia: JB Lippincott Co., 1992:1-15.
24. Harvey E, Schairer CS, Brinton LA, Hoover RN, Fraumeni JF. Alcohol consumption and breast cancer. J Natl Cancer Inst 1987;78:657-61.
25. Gritz ER, Dimatteo MR, Hays RD. Methodological issues in adherence to cancer control regimens. Prev Med 1989; 18:711.
26. King AC, Harris RB, Haskell WL. Effect of recruitment strategy on types of subjects entered into a primary prevention clinical trial. Ann Epidemiol 1994;4:312.
27. Siegler IC, Feaganes JR, Rimer BK. Predictors of adoption of mammography in women under age 50. Health Psych 1995;14:3:1.
28. King E, Rimer BK, Seay J, Balshem A, Engstrom PF. Promoting mammography use through progressive interventions: Is it effective? Am J Public Health 1994;84(1):104.
29. Sandler RS, DeVellis BM, Blalock SJ, Holland KL. Participation of high-risk subjects in colon cancer screening. Cancer 1989;11:2211.
30. Blalock SJ, DeVellis BE, Afifi RA, Sandler RS. Risk perceptions and participation in colorectal cancer screening. Health Psych 1990;9(6):792.
31. McBride CM, Curry SJ, Taplin SH, Anderman C, Grothaus L. Exploring environmental barriers to participation in mammography screening in an HMO. Cancer Epidemiol Biomarkers Prev 1993;2:599.
32. McCabe MS, Varricchio CG, Padberg RM. Efforts to recruit the economically disadvantaged to national clinical trials. Semin Oncol Nurs 1994;2:123.
33. King MC, Rowell S, Love SM. Inherited breast and ovarian cancer: what are the risks? What are the choices? JAMA 1993;269(15):1975.